Annual report
4820.TEDINET S100XUIK
Period2025-01-01 → 2025-12-31
Filed2026-03-26
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥23.7bn | 2025-01-01 → 2025-12-31 | Cons. | Net sales |
| Revenue | ¥24.8bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥20.4bn | 2023-01-01 → 2023-12-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥16.9bn | 2022-01-01 → 2022-12-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥14.4bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥3.7bn | 2025-01-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | ¥4.5bn | 2024-01-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | ¥4.3bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥5.2bn | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.9bn | 2023-01-01 → 2023-12-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.8bn | 2022-01-01 → 2022-12-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.6bn | 2021-01-01 → 2021-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.6bn | 2025-01-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.7bn | 2024-01-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.5bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.4bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.0bn | 2023-01-01 → 2023-12-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.9bn | 2022-01-01 → 2022-12-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.8bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.5bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | ¥2.4bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥27.5bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥31.7bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥29.4bn | at 2023-12-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥26.3bn | at 2022-12-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥24.8bn | at 2021-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.1bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥11.1bn | at 2024-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥20.4bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥20.6bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥20.6bn | at 2023-12-31v | Cons. | Net assets |
| Net assets / equity | ¥19.5bn | at 2022-12-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥18.8bn | at 2021-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥7.8bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥11.9bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥7.8bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.9bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.4bn | at 2023-12-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.9bn | at 2022-12-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥8.3bn | at 2021-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.0bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.8bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.5bn | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.7bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.2bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥194m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.0bn | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥577m | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥544m | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥3.8bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.6bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥993m | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.3bn | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥693m | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥35.44 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥34.54 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.76 | 2023-01-01 → 2023-12-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥26.75 | 2022-01-01 → 2022-12-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.72 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥35.32 | 2025-01-01 → 2025-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥34.43 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.68 | 2023-01-01 → 2023-12-31v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥26.66 | 2022-01-01 → 2022-12-31v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥25.64 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥293.77 | at 2025-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥297.04 | at 2024-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥289.47 | at 2023-12-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥274.94 | at 2022-12-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥263.12 | at 2021-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 73.9% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.8% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.6% | at 2023-12-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.7% | at 2022-12-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.5% | at 2021-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 12.0% | 2025-01-01 → 2025-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.8% | 2024-01-01 → 2024-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.8% | 2023-01-01 → 2023-12-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.9% | 2022-01-01 → 2022-12-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.1% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 858 | at 2025-12-31 | Cons. | Number of employees |
| Employees | 827 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 811 | at 2023-12-31v | Cons. | Number of employees |
| Employees | 592 | at 2022-12-31v | Cons. | Number of employees |
| Employees | 558 | at 2021-12-31d | Cons. | Number of employees |
| Revenue | ¥18.8bn | 2025-01-01 → 2025-12-31 | Standalone | Net sales |
| Revenue | ¥19.9bn | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥17.3bn | 2023-01-01 → 2023-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥16.1bn | 2022-01-01 → 2022-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥13.6bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.8bn | 2025-01-01 → 2025-12-31 | Standalone | Operating income |
| Operating income | ¥3.7bn | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Ordinary income | ¥3.8bn | 2025-01-01 → 2025-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥4.5bn | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.4bn | 2023-01-01 → 2023-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.8bn | 2022-01-01 → 2022-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.5bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.1bn | 2025-01-01 → 2025-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥3.0bn | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Net income | ¥2.2bn | 2025-01-01 → 2025-12-31 | Standalone | Profit loss |
| Net income | ¥2.0bn | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | ¥1.7bn | 2023-01-01 → 2023-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.0bn | 2022-01-01 → 2022-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.0bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥24.1bn | at 2025-12-31 | Standalone | Assets |
| Total assets | ¥28.3bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥26.4bn | at 2023-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥25.2bn | at 2022-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥23.9bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.0bn | at 2025-12-31 | Standalone | Liabilities |
| Total liabilities | ¥8.8bn | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥19.1bn | at 2025-12-31 | Standalone | Net assets |
| Net assets / equity | ¥19.5bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥19.7bn | at 2023-12-31v | Standalone | Net assets |
| Net assets / equity | ¥19.0bn | at 2022-12-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥18.2bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥3.9bn | at 2025-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥8.3bn | at 2024-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥32.22 | 2025-01-01 → 2025-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.06 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥24.12 | 2023-01-01 → 2023-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.79 | 2022-01-01 → 2022-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.6 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥32.12 | 2025-01-01 → 2025-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.97 | 2024-01-01 → 2024-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥24.04 | 2023-01-01 → 2023-12-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.71 | 2022-01-01 → 2022-12-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥28.51 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥39 | 2025-01-01 → 2025-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥35 | 2024-01-01 → 2024-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2023-01-01 → 2023-12-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥12 | 2022-01-01 → 2022-12-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥11 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥275.21 | at 2025-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥281.91 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥278.05 | at 2023-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥267.83 | at 2022-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥255.16 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 79.1% | at 2025-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.8% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.5% | at 2023-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.0% | at 2022-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.1% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 11.6% | 2025-01-01 → 2025-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.1% | 2024-01-01 → 2024-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.8% | 2023-01-01 → 2023-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.6% | 2022-01-01 → 2022-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.7% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 70,514,800 | at 2025-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 70,514,800 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 74,514,800 | at 2023-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 74,514,800 | at 2022-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 74,514,800 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 514 | at 2025-12-31 | Standalone | Number of employees |
| Employees | 497 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 457 | at 2023-12-31v | Standalone | Number of employees |
| Employees | 432 | at 2022-12-31v | Standalone | Number of employees |
| Employees | 413 | at 2021-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 81
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-12-31 | 46 pure |
| Otherother segments | capex | 2025-01-01 → 2025-12-31 | ¥13m |
| Otherother segments | depreciation | 2025-01-01 → 2025-12-31 | ¥10m |
| Otherother segments | revenue | 2025-01-01 → 2025-12-31 | ¥1.1bn |
| Otherother segments | revenue external | 2025-01-01 → 2025-12-31 | ¥994m |
| Otherother segments | revenue intersegment | 2025-01-01 → 2025-12-31 | ¥124m |
| Otherother segments | segment assets | at 2025-12-31 | ¥1.2bn |
| Otherother segments | segment profit | 2025-01-01 → 2025-12-31 | ¥28m |
| Reconciling Itemsreconciling | depreciation | 2025-01-01 → 2025-12-31 | ¥214m |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-12-31 | −¥142m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-12-31 | −¥142m |
| Reconciling Itemsreconciling | segment assets | at 2025-12-31 | ¥15.4bn |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-12-31 | ¥27m |
| Care Welfare IT Systems Businessreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥134m |
| Care Welfare IT Systems Businessreportable segment | employees | at 2025-12-31 | 61 pure |
| Care Welfare IT Systems Businessreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥566m |
| Care Welfare IT Systems Businessreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥566m |
| Care Welfare IT Systems Businessreportable segment | segment assets | at 2025-12-31 | ¥94m |
| Care Welfare IT Systems Businessreportable segment | segment profit | 2025-01-01 → 2025-12-31 | −¥378m |
| Medecl Computerreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥270m |
| Medecl Computerreportable segment | employees | at 2025-12-31 | 177 pure |
| Medecl Computerreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥2.9bn |
| Medecl Computerreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥2.9bn |
| Medecl Computerreportable segment | segment assets | at 2025-12-31 | ¥816m |
| Medecl Computerreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥32m |
| Pharmacy Receipt Computerreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥733m |
| Pharmacy Receipt Computerreportable segment | depreciation | 2025-01-01 → 2025-12-31 | ¥860m |
| Pharmacy Receipt Computerreportable segment | employees | at 2025-12-31 | 533 pure |
| Pharmacy Receipt Computerreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥19.2bn |
| Pharmacy Receipt Computerreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥19.2bn |
| Pharmacy Receipt Computerreportable segment | revenue intersegment | 2025-01-01 → 2025-12-31 | ¥18m |
| Pharmacy Receipt Computerreportable segment | segment assets | at 2025-12-31 | ¥10.0bn |
| Pharmacy Receipt Computerreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥4.0bn |
| —segment total | capex | 2025-01-01 → 2025-12-31 | ¥1.2bn |
| —segment total | depreciation | 2025-01-01 → 2025-12-31 | ¥871m |
| —segment total | revenue | 2025-01-01 → 2025-12-31 | ¥23.8bn |
| —segment total | revenue external | 2025-01-01 → 2025-12-31 | ¥23.7bn |
| —segment total | revenue intersegment | 2025-01-01 → 2025-12-31 | ¥142m |
| —segment total | segment assets | at 2025-12-31 | ¥12.1bn |
| —segment total | segment profit | 2025-01-01 → 2025-12-31 | ¥3.6bn |
| Otherother segments | capex | 2024-01-01 → 2024-12-31 | ¥0 |
| Otherother segments | depreciation | 2024-01-01 → 2024-12-31 | ¥16m |
| Otherother segments | revenue | 2024-01-01 → 2024-12-31 | ¥1.2bn |
| Otherother segments | revenue external | 2024-01-01 → 2024-12-31 | ¥1.0bn |
| Otherother segments | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥152m |
| Otherother segments | segment assets | at 2024-12-31 | ¥1.0bn |
| Otherother segments | segment profit | 2024-01-01 → 2024-12-31 | ¥60m |
| Reconciling Itemsreconciling | depreciation | 2024-01-01 → 2024-12-31 | ¥198m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-12-31 | −¥171m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-12-31 | −¥171m |
| Reconciling Itemsreconciling | segment assets | at 2024-12-31 | ¥19.8bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-12-31 | ¥22m |
| Care Welfare IT Systems Businessreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥381m |
| Care Welfare IT Systems Businessreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥171m |
| Care Welfare IT Systems Businessreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥570m |
| Care Welfare IT Systems Businessreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥570m |
| Care Welfare IT Systems Businessreportable segment | segment assets | at 2024-12-31 | ¥141m |
| Care Welfare IT Systems Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | −¥450m |
| Medecl Computerreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥115m |
| Medecl Computerreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥193m |
| Medecl Computerreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥2.6bn |
| Medecl Computerreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥2.6bn |
| Medecl Computerreportable segment | segment assets | at 2024-12-31 | ¥797m |
| Medecl Computerreportable segment | segment profit | 2024-01-01 → 2024-12-31 | −¥423m |
| Pharmacy Receipt Computerreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥627m |
| Pharmacy Receipt Computerreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥774m |
| Pharmacy Receipt Computerreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥20.7bn |
| Pharmacy Receipt Computerreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥20.7bn |
| Pharmacy Receipt Computerreportable segment | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥19m |
| Pharmacy Receipt Computerreportable segment | segment assets | at 2024-12-31 | ¥9.9bn |
| Pharmacy Receipt Computerreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥5.3bn |
| —segment total | capex | 2024-01-01 → 2024-12-31 | ¥1.1bn |
| —segment total | depreciation | 2024-01-01 → 2024-12-31 | ¥1.2bn |
| —segment total | revenue | 2024-01-01 → 2024-12-31 | ¥25.0bn |
| —segment total | revenue external | 2024-01-01 → 2024-12-31 | ¥24.8bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥171m |
| —segment total | segment assets | at 2024-12-31 | ¥11.8bn |
| —segment total | segment profit | 2024-01-01 → 2024-12-31 | ¥4.4bn |
| Care Welfare IT Systems Businessreportable segment | employees | at 2025-12-31 | 43 pure |
| Medecl Computerreportable segment | employees | at 2025-12-31 | 136 pure |
| Pharmacy Receipt Computerreportable segment | employees | at 2025-12-31 | 306 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,661
| Item | Context | Value | Unit |
|---|---|---|---|
| Term of office information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E05155-000OkamotoShinobuMember | Original text (Japanese)（注）５ | |
| Official title or position information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E05155-000KameiMiwakoMember | Original text (Japanese)取締役（監査等委員） | |
| Name information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E05155-000KameiMiwakoMember | Original text (Japanese)亀井 美和子 | |
| Date of birth information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E05155-000KameiMiwakoMember | 1964-10-31 | |
| Career summary information about directors and corporate auditors proposal (text) | FilingDateInstant_jpcrp030000-asr_E05155-000KameiMiwakoMember | Text · Plus | |
| Term of office information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E05155-000KameiMiwakoMember | Original text (Japanese)（注）５ | |
| Official title or position information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E05155-000AkabaneHidenoriMember | Original text (Japanese)取締役（監査等委員） | |
| Name information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E05155-000AkabaneHidenoriMember | Original text (Japanese)赤羽根 秀宜 | |
| Date of birth information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E05155-000AkabaneHidenoriMember | 1975-02-21 | |
| Career summary information about directors and corporate auditors proposal (text) | FilingDateInstant_jpcrp030000-asr_E05155-000AkabaneHidenoriMember | Text · Plus | |
| Term of office information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E05155-000AkabaneHidenoriMember | Original text (Japanese)（注）４ | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row3Member | Text · Plus | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row4Member | Text · Plus | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row5Member | Text · Plus | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row6Member | Text · Plus | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row7Member | Text · Plus | |
| Outside directors and outside corporate auditors (text) | FilingDateInstant | Text · Plus | |
| Audits (text) | FilingDateInstant | Text · Plus | |
| Remuneration for directors and other officers (text) | FilingDateInstant | Text · Plus | |
| Shareholdings (text) | FilingDateInstant | Text · Plus | |
| Reason for increase in number of shares shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | Original text (Japanese)第三者割当増資の引受 | |
| Reason for increase in number of shares shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Description of fact that financial statements have been prepared in accordance with special provision financial information | CurrentYearDuration | Original text (Japanese)また、当社は、特例財務諸表提出会社に該当し、財務諸表等規則第127条の規定により財務諸表を作成しております。 | |
| Note on independent audit financial information | CurrentYearDuration | Text · Plus | |
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial information | CurrentYearDuration | Text · Plus | |
| Consolidated balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of cash flows (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies for preparation of consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Number of consolidated subsidiaries and names of major consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and reasons for exclusion from scope of consolidation (text) | CurrentYearDuration | Text · Plus | |
| Number of unconsolidated subsidiaries and associates accounted for using equity method and names of major entities accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and associates and reasons for not being accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Disclosure about fiscal years etc of consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Disclosure of accounting policies (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes new accounting standards not yet applied consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in presentation consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding shares and bonds etc of unconsolidated subsidiaries and associates (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amounts of notes and accounts receivable trade and contract assets (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amount of revenue from contracts with customers (text) | CurrentYearDuration | Text · Plus | |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding loss on disposal of property plant and equipment (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding impairment loss (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |